🫀 What happens to symptoms after an HF hospitalization?
A #HFSA2026 SimPub from our sister journal, JCF Intersections, explores dyspnea trajectories and the need for continued symptom support.
Read more: https://bit.ly/4yLFAPm
@jcardfail.bsky.social
@jcardfail.bsky.social🫀 What happens to symptoms after an HF hospitalization?
A #HFSA2026 SimPub from our sister journal, JCF Intersections, explores dyspnea trajectories and the need for continued symptom support.
Read more: https://bit.ly/4yLFAPm
@jcardfail.bsky.socialWhat's on the research radar today? 🔬
JCF is highlighting another collection of simultaneous publications from #HFSA2026.
Explore the newly released papers - links below 👇
@jcardfail.bsky.social🔎 Could signs of cardiac amyloidosis appear years before diagnosis?
Our sister journal, JCF Intersections, explores early clues to wtATTR-CA in its #HFSA2026 SimPub.
Read the research: bit.ly/4ye1EkA
@jcardfail.bsky.socialThe #HFSA2026 research keeps coming! 🔬
We're back with another round of JCF simultaneous publications from the Annual Scientific Meeting.
Catch up on Saturday's latest papers - links below 👇
@womenasone.bsky.socialToday at #HFSA2026!
Join us to explore why cardiac amyloidosis is underdiagnosed in women, how to improve diagnosis, whether treatment guidelines should evolve and how to improve the patient experience.
Register now to learn and build connections: womenasonepulse.org/...
@jcardfail.bsky.social🚨 #HFSA2026 SimPub alert!
The HFSA Annual Scientific Meeting is underway, and the first round of JCF simultaneous publications is here!
Explore Friday's newly released research:
https://bit.ly/47KnNMB
https://bit.ly/3VGkKlZ
https://bit.ly/4hFhQXi
@womenasone.bsky.socialOne week to go!
Join us on October 10 in Phoenix during #HFSA2026 to explore why cardiac amyloidosis is underdiagnosed in women, how diagnosis can improve, and whether treatment guidelines should evolve.
Let’s work toward more equitable care.
Register: womenasonepulse.org/...
@womenasone.bsky.socialWhen amyloidosis is underdiagnosed in women, opportunities for earlier treatment can be missed.
At #HFSA2026, we’ll explore sex-specific gaps in diagnosis & care, from improving diagnostic accuracy to whether treatment guidelines should evolve.
Join us: womenasonepulse.org/...
@womenasone.bsky.social2 weeks to go!
Join us on October 10 at #HFSA2026 as we explore why cardiac amyloidosis is underdiagnosed in women, how to improve diagnostic accuracy, & whether treatment guidelines should evolve.
Let’s keep moving toward more equitable care.
Join us: womenasonepulse.org/...
@womenasone.bsky.socialHow can we close gaps in the diagnosis & treatment of amyloidosis in women?
At #HFSA2026, leading clinicians will explore underdiagnosis, diagnostic accuracy, treatment guidelines & patient experiences, with a focus on advancing equity.
Join us: womenasonepulse.org/...
@womenasone.bsky.socialAre women with cardiac amyloidosis being diagnosed & treated equitably?
Join us & BridgeBio Pharma Inc. at #HFSA2026 to explore why amyloidosis is underdiagnosed in women, how sex differences affect care & whether treatment guidelines should evolve.
Register: womenasonepulse.org/...
